Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 32.30
+0.14 (0.44%)
Oct 21, 2025, 5:31 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 1.25 billion as of October 21, 2025. Its market cap has increased by 90.59% in one year.
Market Cap
1.25B
Enterprise Value
1.24B
Revenue
103.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.30
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 1.25B, a decrease of -61.47%. That is a compound annual growth rate of -9.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 1.25B | 55.43% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | 66.24M | 20.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 243.21B |
| Novartis AG | 201.75B |
| Lonza Group AG | 38.88B |
| Galderma Group AG | 32.50B |
| Alcon | 29.43B |
| Sandoz Group AG | 20.85B |
| Straumann Holding AG | 13.86B |
| Sonova Holding AG | 12.96B |